Pharma: Novartis invests billions in partnership with Argo Biopharma

Swiss pharmaceutical giant Novartis is expanding its partnership with Argo Biopharma, paying USD 160 million upfront for access to innovative cardiovascular therapies.

Amelie Richter

04. September 2025

Small Medium Large

Recipients need a subscription to read

Share on Bluesky Share via email Print

Amelie Richter

04. September 2025

Small Medium Large

Recipients need a subscription to read

Share on Bluesky Share via email Print

Last updated: 04. September 2025